Eyes itching from allergies? Ocular's Dextenza wins FDA approval as first monthly implant

Patients with itchy eyes caused by allergic inflammation often take eye drops multiple times per day. Thanks to an FDA approval, a monthly insert into the canaliculus of the eye will soon be available.

Monday, the FDA approved Ocular Therapeutix’s Dextenza to treat eye itching associated with allergic conjunctivitis, making it the first physician-administered insert that treats the disease for up to 30 days with one administration. The med is a preservative-free, resorbable hydrogel that contains the popular corticosteroid dexamethasone as its active ingredient.